BPC-157, in particular, has been among the most publicly discussed peptides, with prominent advocates citing its potential benefits for injury recovery

IN THIS EPISODE - Taras lifelong experience with obesity, dieting, and weight stigma - How a radio ad and a clinical-trial opening changed the course of her life - What it was like to join an early tirzepatide trial with only a 25% chance of receiving the medication - The role of nutrition support, movement, and gradual behavior change - Losing 132 pounds in 18 monthsand what happened when the trial ended - Navigating medication access, shortages, judgment, and compounded medication - Why the scale and clothing sizes can become a new kind of obsession - Recognizing when continued weight loss was no longer healthy - What long-term maintenance looks like after a major weight change - Using medication as one tool in a broader, ongoing relationship with health ABOUT THE GUEST Tara Rothenhoefer is a wife, mom, and grandma who, after a lifelong battle with obesity, joined a clinical trial for tirzepatide in 2020 that led to her 222-pound weight loss

The concentrations of tannin, phytate, and oxalate varied from 38.8 to 51.5, 269.6 to 293.0, and 28.2 to 71.4 mg/100 g respectively [36]
Journal reference: Sawicka-Gutaj N, Gruszczyski D, Nijakowski K, et al